Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non–Insulin-Treated Diabetes Mellitus

Authors:

Abstract
Patients with diabetes mellitus (DM) often have rapidly progressive, extensive coronary artery disease leading to long and diffuse lesions in small-caliber coronary arteries, which renders revascularization challenging.1 As such, when compared with patients without DM, patients with DM have had worse outcomes following percutaneous coronary intervention (PCI) in the balloon angioplasty era, bare-metal stent (BMS) era, and even in the drug-eluting stent era, with higher rates of in-stent restenosis, stent thrombosis, death, and myocardial infarction (MI).1-4 Among patients with DM undergoing revascularization, those treated with insulin have been shown to have worse outcomes compared with those not treated with insulin.5-8 However, this finding is controversial, as other studies have shown that the increased possibility of adverse cardiovascular outcomes in patients with insulin-treated DM (ITDM) disappears after risk adjustment.9

This publication has 13 references indexed in Scilit: